Doctor Zhao, help!

Chapter 341: Focus on technology

"In fact, if the study of telomerase really extends human lifespan greatly, then the medical system will need to adjust to adapt to this change. By then, more doctors, nurses and other health care professionals will be needed. , as well as more medical equipment and medicines.”

"By then, the lives of doctors and nurses will definitely be easy."

Zhao Sheng thought for a while and said again.

"This is normal. As human lifespan increases, more anti-aging products and services may appear. Longevity may lead to more demand for medical care. In this way, the demand for medical staff will greatly increase. .”

Jin Dong smiled and said, although Zhao Sheng thought a little too far, it is always good to have dreams.

“This is probably the only way I can think of to disrupt the medical industry.”

Zhao Sheng said.

No one wants to die prematurely if they can live a long life. Extending life span does not mean that all diseases will be eliminated. Simply put, by that time, a large number of people will invest their money in extending life span and health care.

By that time, the entire medical industry will inevitably become popular again, and there will definitely be no need for medical staff to feel sad or have enough to eat.

"Uh~"

"Junior, you are quite crooked..."

When Zhao Sheng said this, Jin Dong couldn't help but be startled for a moment before he said.

Although it sounds a bit too far away, Jindong knows that there are actually a lot of people willing to invest in this area of ​​research.

"I heard that the vice president of a certain company invested in research and development for ALS and has produced results. Is this true?"

After hearing this, Tang Wen asked very curiously.

Although she couldn't understand the professional part of the chat between Zhao Sheng and Jin Dong, she could still understand the topic of extending life span and slowing down aging.

“It is too difficult to conquer a rare disease from scratch.”

Jin Dong shook his head slightly and said.

Although he is the vice president of Moudong and has a large net worth, it can be said that all the money has been invested in scientific research to overcome ALS. However, compared with the research and development of a new drug for rare diseases, these investments are lower than those of large pharmaceutical groups. The investment is still too little.

The research and development of a new drug is much more difficult than people think.

Generally speaking, a new drug needs to go through a very long research and development process from the idea in the minds of scientists to the actual use by patients, such as the discovery of disease targets, screening and optimization of candidate compounds, preclinical pharmacology and toxicology, and Quality research, Phase III clinical research, application and registration, large-scale production, etc. Each stage has countless small stages. If anything goes wrong in any link, it will fail. Not to mention a narrow escape, even a hundred deaths, it will not be passed.

Therefore, instead of spending a lot of manpower, material resources and investment to research new drugs, it is better to change the packaging, or even change the name, and re-enter the market, and you can make several times the money.

No matter how bad it is, if you invest money in a popular industry, you will just wait for asset growth. Why do you need to do such a thankless task as developing new drugs?

In addition, drug development to final marketing is a complex process involving multiple stages and factors.

All new drugs need to undergo rigorous clinical trials to verify their safety and effectiveness. If the clinical trial results are unsatisfactory, the drug may not be approved by regulatory agencies and cannot be marketed.

"If there is a new drug, he can use it himself, but other patients with ALS may not be able to use it so easily."

Zhao Sheng also shook his head slightly and said. For a newly developed new drug, safety is one of the most important considerations. If a drug is found to have serious safety hazards or side effects after clinical trials, the promotion of the drug may be restricted or even suspended. At the same time, the marketing of drugs requires approval from drug regulatory agencies (such as FDA, EMA, etc.). These institutions will strictly review the research data, clinical trial results, safety, etc. of the drug. If a drug fails to meet regulatory standards, it will not be approved. Sometimes, although the preliminary experimental results look promising, technical difficulties may be encountered in the subsequent development process, causing the drug development process to slow down or even fail.

Some cutting-edge scientific research may not have been fully verified, resulting in some so-called "miracle drugs" failing to achieve their advertised effects after rigorous clinical verification. Or, sometimes the clinical value of the drug may not reach a high enough level, or the effect may not be obvious in a specific population, thus limiting the promotion of the drug.

Therefore, it takes a long time and a lot of money to verify and advance a drug from being proven effective in the laboratory to actually being used on patients. Generally speaking, it can take 10 years or more from the discovery of a drug to its final launch. A new drug may require hundreds of millions to billions of dollars of investment from discovery to launch.

"So that's it."

"So what about the stem cell treatment you're doing? Is it any different from research and development?"

Tang Wen nodded and asked Jin Dong curiously.

"Stem cell therapy is a treatment, and you can think of it as a special surgery, so the restrictions are much smaller than the difficulty of developing and putting a new drug into use."

Jin Dong explained.

"You two are like two swords combined. I look forward to your future."

Tang Wen said with some sigh, although she is not in the medical industry, if she can see any breakthrough progress in medical research, such as greatly extending life span, then she will definitely be happy to see the results and be excited. .

Who doesn't want to live longer?

"Yes, ordinary people like us rely on geniuses like you."

Teacher Tang, who had been silent all this time, also smiled and said.

"As far as the domestic environment is concerned, developing a technology is far more profitable than developing a new drug."

Jin Dong didn't know what he was thinking of, and said with great feeling.

It's simple, because technology is in people's hands.

The formula and production process of new drugs, and even patents, can completely squeeze out the developers.

I won’t say too much about this aspect.

"Junior, I have already told Professor Yu about this matter. For now, I can only work hard and you can only run on both sides."

Jin Dong said to Zhao Sheng again.

Things have to happen step by step, and it is impossible for Zhao Sheng to just throw away the problem and leave.

However, even people like Yu Zhongbo have thoughts of leaving, which is already very revealing.

"I originally thought it would be a good thing for a teacher to be the dean."

Zhao Sheng also didn't know what to say. He thought of a possibility, that is, this situation of dichotomy of doctors was actually expected by policymakers, or was this the desired effect?

(End of this chapter)